Jun 27
Viridian launches first commercial product as U.S. approves thyroid eye disease therapy
Synthesized from 14 sources
Sources (14)
Bias Scale:
LeftCenterRight
Seeking AlphaJun 27, 2026, 6:00 PM
Apple lobbying to buy memory chips from blacklisted Chinese firm: FTThe VergeJun 27, 2026, 5:28 PM
Apple wants permission to buy memory from a blacklisted Chinese supplierSeeking AlphaJun 27, 2026, 4:52 PM
Anthropic soon to win U.S. clearance to restore Fable 5: AxiosTechCrunchJun 27, 2026, 4:45 PM
Apple Vision Pro exec is reportedly leaving for OpenAICNBCJun 27, 2026, 4:39 PM
The AI trade cooled and oil sank. A closer look at Wall Street's volatile weekSeeking AlphaJun 27, 2026, 4:20 PM
BioLife is said to have drawn takeover interest from RepligenSeeking AlphaJun 27, 2026, 3:37 PM
Viridian launches first commercial product as U.S. approves thyroid eye disease therapyBloombergJun 27, 2026, 2:00 PM
Soaring iPad, Xbox Prices Reveal Pain of Memory Chip MessReutersJun 27, 2026, 1:13 PM
US close to allowing Anthropic to restore Fable 5 model, Axios reportsCNBCJun 27, 2026, 1:12 PM
Alphabet burnishes one of its best weapons in the battle for AI supremacyFinancial TimesJun 27, 2026, 11:00 AM
German carmakers embark on historic job cuts as Chinese rivals flood marketFinancial TimesJun 27, 2026, 9:30 AM
Chart of the Week: Chipmakers are expensive globallyCNBCJun 26, 2026, 9:33 PM
AI trade is not dead, says Deepwater's Gene MunsterCNBCJun 26, 2026, 9:23 PM
How Z.AI is closing in on America's AI frontierComments
No comments yet. Be the first!